THIS PAGE IS UNDER CONSTRUCTION
Related Pages
References
Copyright 2019, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other lay persons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Related Pages
Does estrogen have a role in schizophrenia?
Estrogen as a treatment for schizophrenia?
Can oral contraceptives affect clozapine levels?
Potential risks of estrogen therapy
References
Bratek A, Krysta K, Drzyzga K, Barańska J, Kucia K. The role of selective estrogen receptor modulators in the treatment of schizophrenia. Psychiatr Danub. 2016 Sep;28(Suppl-1):45-48. PubMed PMID: 27663804.
de Boer J, Prikken M, Lei WU, Begemann M, Sommer I. The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis. NPJ Schizophr. 2018 Jan 10;4(1):1. doi: 10.1038/s41537-017-0043-3. Review. PubMed PMID: 29321530; PubMed Central PMCID: PMC5762671.
Grigg J, Worsley R, Kulkarni J. Raloxifene for schizophrenia and symptoms of
Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Sep 1;73(9):947-54.
Kulkarni J, Gilbert H, Gurvich C, de Castella A, Fitzgerald P, Davis S. The use of selective estrogen receptor modulators in the treatment of menopausal women with schizophrenia. Acta Neuropsychiatr. 2006 Dec;18(6):258. doi:10.1017/S0924270800030477. PubMed PMID: 27397204.
Kulkarni J, Gurvich C, Lee SJ, Gilbert H, Gavrilidis E, de Castella A, Berk M, Dodd S, Fitzgerald PB, Davis SR. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology. 2010 Sep;35(8):1142-7.
Weickert TW, Weinberg D, Lenroot R, Catts SV, Wells R, Vercammen A, O’Donnell M, Galletly C, Liu D, Balzan R, Short B, Pellen D, Curtis J, Carr VJ, Kulkarni J, Schofield PR, Weickert CS. Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Mol Psychiatry. 2015 Jun;20(6):685-94. doi: 10.1038/mp.2015.11. Epub 2015 May 18. PubMed PMID: 25980345; PubMed Central PMCID: PMC4444978.
Copyright 2019, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other lay persons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply: